Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2026-04-09 @ 6:49 PM
Study NCT ID:
NCT06220318
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-28
First Post:
2024-01-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Assessment of the Safety and Efficacy of C019199 Plus Sintilimab in Participants With Advanced Solid Tumors
Sponsor:
Fujian Haixi Pharmaceuticals Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-19
Start Date Type:
ACTUAL
Primary Completion Date:
2026-08-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-08-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-14
First Submit QC Date:
None
Study First Post Date:
2024-01-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-25
Last Update Post Date:
2025-11-28
Last Update Post Date Type:
ESTIMATED